Adelaide Biodesign is a 12 month course running annually, in which multidisciplinary teams identify unmet clinical needs and work towards providing a solution, whilst learning about the medical device development process. Adelaide Biodesign incorporates the highly successful eChallenge as well as mentoring and support from the ThincLab incubator thanks to generous support from the University of Adelaide and Flinders University.
Who should apply?
The typical structure of a Biodesign Australia team includes passionate individuals with a clinical, engineering, business and/or research background. Further we are seeking optimal diversity in teams and cohorts and welcome different age groups, experience levels, gender, and ethnicity. Our participants range from senior students to experienced professionals, however we encourage anyone with a strong passion for medtech and healthcare innovation to make an enquiry.
Kiara Bechta-Metti is the Director, Adelaide Enterprise, the technology transfer office for the University of Adelaide, which has a mandate to accelerate commercialisation through licensing and new start-up companies. Kiara has more than 20 years' experience in technology commercialisation, finance and new business creation in Australia and the United States. From 2005-2014, Kiara led the commercialisation on a wide range of technologies developed at CSIRO across the fields of agriculture, food, health and mining. Prior to CSIRO, she was a financial analyst in equities research at global financial firms UBS and Deutsche Bank, with a focus on healthcare, medical device and biotechnology companies. Kiara started her career working for several Silicon Valley-based biotechnology firms, after completing her degree from UC Berkeley in Molecular and Cellular Biology.
Prof Paul Rolan
Professor Paul Rolan is a clinical pharmacologist, drug developer and physician whose career has been divided between university and pharmaceutical industry both in Australia and the UK. He took a key role in developing a university spin out clinical research company in Manchester, UK to become the largest clinical research unit in the country. He returned to Australia in 2005 where he was Professor of Clinical Pharmacology at the University of Adelaide before joining a small team taking the first Singaporean based pharmaceutical company to listing on the local stock market. Since 2016 he has been the Director of Innovation at the Faculty of Health and Medical Sciences at the University of Adelaide, bringing innovations to undergraduate and postgraduate education, with a focus on commercialisation and entrepreneurial skills. He has been principal investigator in over 700 clinical research studies, is an angel investor and continues to advise pharmaceutical companies on drug development.
Amanda Lee is the Office Manager, Adelaide Enterprise, the technology transfer and commercialisation arm of the University of Adelaide. A finalist in the South Australian Young Business Leaders Program 2013, Amanda’s skillset lies in the organisation of people, programs and projects. With multidisciplinary experience at the University of Adelaide since 2012, she is enthusiastic about contributing to the positive impact that is had by taking South Australian research and ideas to their full potential. Responsible for the facilitation of Adelaide Biodesign, Amanda is the first point of contact for any course enquiries you may have.
Applications for Adelaide Biodesign 2019 are now closed.
Use the form below to express interest in the 2020 course or lodge an enquiry.